Inventor
HONG ZHI
US45 patents
⚠️ This page may combine multiple inventors who share the name “HONG ZHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GIRARDET JEAN-LUC
8 patentsUS8106205B2Jan 31, 2012
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]p-amino benzoic acids as HIV reverse transcriptase inhibitors
GIRARDET JEAN-LUC13 citations92
US8552043B2Oct 8, 2013
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitors
GIRARDET JEAN-LUC5 citations83
US8252828B2Aug 28, 2012
S-triazolyl α-mercapto acetanilides as inhibitors of HIV reverse transcriptase
GIRARDET JEAN-LUC7 citations83
US8481581B2Jul 9, 2013
S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
GIRARDET JEAN-LUC3 citations62
US8227601B2Jul 24, 2012
Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of HIV
GIRARDET JEAN-LUC4 citations61
US8946273B2Feb 3, 2015
S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptase
GIRARDET JEAN-LUC3 citations60
US8324223B2Dec 4, 2012
Substituted thieno [2,3-d] pyrimidines as HIV inhibitors
GIRARDET JEAN-LUC0 citations51
US8211898B2Jul 3, 2012
Substituted thieno[3,2-d]pyrimidines as HIV inhibitors
GIRARDET JEAN-LUC0 citations51
ARDEA BIOSCIENCES INC
7 patentsUS7435752B2Oct 14, 2008
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benozioc acids as HIV reverse transcriptase inhibitors
ARDEA BIOSCIENCES INC50 citations95
US7820664B2Oct 26, 2010
Inhibitors of MEK
ARDEA BIOSCIENCES INC37 citations92
US7683087B2Mar 23, 2010
N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl] -p-amino benzoic acids as HIV reverse transcriptase inhibitors
ARDEA BIOSCIENCES INC34 citations92
US7595324B2Sep 29, 2009
Substituted thieno[3,2-D]pyrimidines as HIV inhibitors
ARDEA BIOSCIENCES INC7 citations72
US7429667B2Sep 30, 2008
Phenylamino isothiazole carboxamidines as MEK inhibitors
ARDEA BIOSCIENCES INC7 citations71
US7652047B2Jan 26, 2010
Phenylamino isothiazole carboxamidines as MEK inhibitors
ARDEA BIOSCIENCES INC4 citations60
US8354532B2Jan 15, 2013
Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
ARDEA BIOSCIENCES INC0 citations51
RIBAPHARM INC
4 patentsUS6833361B2Dec 21, 2004
Nucleosides having bicyclic sugar moiety
RIBAPHARM INC184 citations98
US6815542B2Nov 9, 2004
Nucleoside compounds and uses thereof
RIBAPHARM INC99 citations96
US6831069B2Dec 14, 2004
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
RIBAPHARM INC51 citations95
US6906190B2Jun 14, 2005
Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
RIBAPHARM INC1 citations48
VALEANT RES & DEV
4 patentsUS7081449B2Jul 25, 2006
Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides
VALEANT RES & DEV72 citations97
US7247621B2Jul 24, 2007
Antiviral phosphonate compounds and methods therefor
VALEANT RES & DEV39 citations92
US6989451B2Jan 24, 2006
Heterocyclic compounds and uses thereof
VALEANT RES & DEV31 citations88
US7371857B2May 13, 2008
Synthesis for hydroxyalkylated heterocyclic bases
VALEANT RES & DEV4 citations61
SCHERING CORP
4 patentsUS6434489B1Aug 13, 2002
Compositions of hepatitis C virus NS5B polymerase and methods for crystallizing same
SCHERING CORP12 citations71
US6297005B1Oct 2, 2001
De novo priming activity of hepatitis C virus replicase
SCHERING CORP6 citations68
US6326137B1Dec 4, 2001
Hepatitis C virus protease-dependent chimeric pestivirus
SCHERING CORP14 citations67
US6967075B2Nov 22, 2005
HCV replicase complexes
SCHERING CORP3 citations56
ARDEA BIOSCIENCES
3 patentsUS7759518B2Jul 20, 2010
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
ARDEA BIOSCIENCES41 citations94
US7897624B2Mar 1, 2011
Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
ARDEA BIOSCIENCES16 citations82
US7842836B2Nov 30, 2010
N-aryl-N'alkyl sulfamides as MEK inhibitors
ARDEA BIOSCIENCES7 citations73
BRII BIOSCIENCES INC
3 patentsUS11890297B2Feb 6, 2024
Combination therapy for HIV with adenosine derivative and capsid inhibitors
BRII BIOSCIENCES INC3 citations74
US12257264B2Mar 25, 2025
Combination therapy for HIV with adenosine derivative and capsid inhibitors
BRII BIOSCIENCES INC0 citations62
US12370200B2Jul 29, 2025
Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof
BRII BIOSCIENCES INC0 citations61